Article3 Biotech2025
Triclosan promotes neurotoxicity in diabetic conditions: an in vivo molecular assessment using zebrafish model.
Article in 3 Biotech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Abnormal lipid metabolism in senescent renal tubular cells in diabetic nephropathy.Cellular and molecular life sciences : CMLS · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The widespread environmental presence of triclosan (TC), a common antimicrobial agent, has raised concerns about its potential metabolic and neurological effects, particularly in susceptible populations such as individuals with diabetes. This study investigated the neuronal effects of TC in streptozotocin (STZ)-induced diabetic zebrafish larvae using network pharmacology, toxicity assays, and gene expression analysis. Network pharmacology identified 99 overlapping diabetes-related targets, with KEGG analysis implicating AGE-RAGE signaling and cholinergic synapse pathways in diabetic and neuronal complications. Acute toxicity testing revealed that TC and STZ co-exposure caused developmental abnormalities, including pericardial edema, and reduced survival (48%) compared to TC (76%) or STZ (68%) alone. Oxidative stress assays demonstrated synergistic reactive oxygen species elevation in the TC + STZ group, supported by upregulated antioxidant enzymes and glutathione-related genes. Neuronal toxicity assessments showed reduced acetylcholinesterase (AChE) activity and impaired locomotor behavior in diabetic larvae exposed to TC, indicating disrupted cholinergic signaling and cognitive dysfunction. Behavioral analyses confirmed hypoactivity and erratic swimming patterns, aligning with oxidative stress and neuroinflammation. These findings suggest that TC exacerbates diabetes-associated hyperglycemia, oxidative stress, and neurotoxicity, with synergistic effects under diabetic conditions. The study highlights the need for diabetes-specific therapeutic strategies, such as antioxidant and neuroprotective interventions, and stricter safety guidelines for TC use in diabetic populations. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-025-04352-z.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.